Nikko Asset Management Americas, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $8.64 Billion
- Q3 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 28,884 shares of REGN stock, worth $19.4 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
28,884
Previous 30,997
6.82%
Holding current value
$19.4 Million
Previous $32.6 Million
6.8%
% of portfolio
0.35%
Previous 0.38%
Shares
23 transactions
Others Institutions Holding REGN
# of Institutions
1,500Shares Held
83MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.27 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.68 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.04 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.3 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.89 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...